|
Volumn 8, Issue 11, 2007, Pages 24-35
|
Using natural history to guide management of chronic hepatitis B
|
Author keywords
[No Author keywords available]
|
Indexed keywords
ADEFOVIR;
ADEFOVIR DIPIVOXIL;
ALANINE AMINOTRANSFERASE;
CLEVUDINE;
ENTECAVIR;
HEPATITIS B(E) ANTIGEN;
INTERFERON;
INTRON A REDIPEN;
LAMIVUDINE;
NUCLEOSIDE ANALOG;
NUCLEOTIDE;
PEGINTERFERON;
PEGINTERFERON ALPHA2A;
PEGINTERFERON ALPHA2B;
PLACEBO;
RECOMBINANT ALPHA2A INTERFERON;
RECOMBINANT ALPHA2B INTERFERON;
TELBIVUDINE;
TENOFOVIR;
UNCLASSIFIED DRUG;
ANOREXIA;
BONE MARROW SUPPRESSION;
CLINICAL TRIAL;
DRUG INDICATION;
FATIGUE;
FLU LIKE SYNDROME;
FOLLOW UP;
HAIR LOSS;
HEPATITIS B;
HIGH RISK PATIENT;
HUMAN;
IMMUNIZATION;
IMMUNOLOGICAL TOLERANCE;
LIVER CELL CARCINOMA;
LIVER FAILURE;
LIVER FIBROSIS;
LIVER FUNCTION TEST;
MALE HOMOSEXUAL;
MENTAL INSTABILITY;
MONOTHERAPY;
MOOD DISORDER;
MORTALITY;
NEUTROPENIA;
OUTPATIENT DEPARTMENT;
PATIENT CARE;
PATIENT EDUCATION;
PATIENT REFERRAL;
PRIMARY PREVENTION;
REVIEW;
RISK REDUCTION;
SCREENING;
SEROCONVERSION;
SIDE EFFECT;
SUICIDE;
THROMBOCYTOPENIA;
TREATMENT DURATION;
VIRUS REPLICATION;
VIRUS TRANSMISSION;
WEIGHT REDUCTION;
|
EID: 37149010149
PISSN: 1443430X
EISSN: None
Source Type: Journal
DOI: None Document Type: Review |
Times cited : (3)
|
References (0)
|